IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. beats earnings expectations. Reported EPS is $2.81, expectations were $2.7.
Stay updated with breaking news from Procyte One. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IDEXX Laboratories, Inc. beats earnings expectations. Reported EPS is $2.81, expectations were $2.7.
/PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the IDEXX inVue Dx™ Cellular...
IDEXX benefits from strong secular growth and its ability to turn high growth into rapidly rising free cash flow used to buy back stock. Read more about IDXX.
Operator: Good morning, and welcome to the IDEXX Laboratories Fourth Quarter 2022 Earnings Conference Call. As a reminder, today's conference is being recorded.
IDEXX Laboratories, Inc. (NASDAQ:NASDAQ:IDXX) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ETCompany ParticipantsBrian McKeon - Executive Vice President, Chief Financial Officer...